Drug General Information
Drug ID
D08RJY
Drug Name
Anti-EGFRvIII CAR transduced PBL
Drug Type
CAR T Cell Therapy
Indication Brain cancer [ICD-11: 2A00] Phase 1/2 [1]
Malignant glioma [ICD-11: 2A00.0; ICD-9: 191] Phase 1/2 [1]
Recurrent glioblastoma [ICD-11: 2A00.00; ICD-10: C71] Phase 1/2 [1]
Company
National Cancer Institute (NCI)
Target and Pathway
Target(s) Epidermal growth factor receptor variant III (EGFR vIII) Target Info CAR-T-Cell-Therapy [1]
References
REF 1 ClinicalTrials.gov (NCT01454596) CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.